Skip to Content Skip to Navigation

Over ons Praktische zaken Waar vindt u ons S. van der Schans, MSc

University Medical Center Groningen

S. van der Schans, MSc

Geen foto beschikbaar

Faculteit Medische Wetenschappen/UMCG

Telefoon:

E-mail:

s.van.der.schans umcg.nl

ORCID Research Portal

Publicaties

Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands

van der Schans, S., Velikanova, R., Weidlich, D., Howells, R., Patel, A., Bischof, M., Postma, M. J. & Boersma, C., 2025, In: European Journal of Health Economics. 26, blz. 1101-1110 10 blz.

Onderzoeksoutput: Article › › peer review

Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling—The Tool of Choice for Assessing Public Finance Sustainability

van der Schans, S., Schöttler, M. H., van der Schans, J., Connolly, M. P., Postma, M. J. & Boersma, C., apr.-2023, In: Vaccines. 11, 4, 19 blz., 823.

Onderzoeksoutput: Article › › peer review

Monitoring physical impact and recovery of pancreatic cancer treatment using consumer wearable health data: A case report

van der Schans, C. P., van der Schans, S., van der Schans, J., Mylius, C. & Klaase, J., 22-mei-2023, In: Digital Health. 9, 4 blz.

Onderzoeksoutput: Article › › peer review

A novel perspective on pharmaceutical R&D costs: opportunities for reductions

van der Schans, S., De Loos, F., Boersma, C., Postma, M. J. & Büller, H., 2022, In: Expert review of pharmacoeconomics & outcomes research. 22, 2, blz. 167-175 9 blz.

Onderzoeksoutput: Article › › peer review

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands

Velikanova, R., van der Schans, S., Bischof, M., van Olden, R. W., Postma, M. & Boersma, C., okt.-2022, In: Value in Health. 25, 10, blz. 1696-1704 9 blz.

Onderzoeksoutput: Article › › peer review

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

Hagendijk, M. E., van der Schans, S., Boersma, C., Postma, M. J. & van der Pol, S., aug.-2021, In: European Journal of Health Economics. 22, 6, blz. 991-999 9 blz.

Onderzoeksoutput: Article › › peer review

The impact of patent expiry on drug prices: insights from the Dutch market

van der Schans, S., Vondeling, G. T., Cao, Q., van der Pol, S., Visser, S., Postma, M. J. & Rozenbaum, M. H., 1-dec.-2020, In: Journal of market access & health policy. 9, 1, 1849984.

Onderzoeksoutput: Article › › peer review

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations

van der Schans, S., Goossens, L. M. A., Boland, M. R. S., Kocks, J. W. H., Postma, M. J., van Boven, J. F. M. & Rutten-van Molken, M. P. M. H., jan.-2017, In: Pharmacoeconomics. 35, 1, blz. 43-63 21 blz.

Onderzoeksoutput: Review article › peer review

Alle (8) publicaties

Bekijk volledig onderzoeksprofiel

Volg de RUGfacebook linkedin rss instagram youtube